This Week in Cancer Discovery | GenomeWeb

This Week in Cancer Discovery

Premium

In Cancer Discovery this week, researchers in the UK and Switzerland report they performed a functional metabolic screen to identify the gene PFKFB4 as an important regulator of prostate cancer cell survival. The team analyzed the effect of silencing 222 different enzymes, transporters, and regulators on the survival of three metastatic prostate cancer cell lines and one non-malignant prostate cancer cell line and found that there are several genes required for the cells' survival.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.